Advancements in Patient-Centered Care

Cortisol in Oncology: An Emerging Area of Scientific Inquiry

May 29, 2026

Emerging research is exploring how cortisol signaling and glucocorticoid receptor (GR) activation may influence tumor biology, therapeutic resistance, and treatment response across oncology care. This article examines the evolving science behind GR signaling, its potential clinical implications, and the growing interest in how stress biology and supportive care intersect with cancer treatment.

NCODA and Leading Cancer Community Partners Issue Consensus Statementon U.S. Drug Shortages, Urge Policy Action

May 13, 2026

Today, NCODA, in partnership with organizations across the cancer community, released a consensus statement identifying the primary drivers of the persistent drug shortage crisis in the United States and proposing actionable policy solutions to protect access to critical cancer medications.

NCODA Leaders and Partners to Present at Asembia 2026 on Advancing Medically Integrated Oncology Care

April 27, 2026

NCODA Leaders and Partners to Present at Asembia 2026 on Advancing Medically Integrated Oncology Care

Bispecific T-Cell Engagers (BTCEs) Directory

April 9, 2026

NCODA’s veteran support resources provide oncology care teams with guidance, tools, and strategies to deliver coordinated, patient-centered care for veterans across clinical and community settings.

NCODA Resource Guide

April 8, 2026

NCODA’s veteran support resources provide oncology care teams with guidance, tools, and strategies to deliver coordinated, patient-centered care for veterans across clinical and community settings.

NCODA Veteran Support Resources: Serving Those Who Served Our Country

April 8, 2026

NCODA’s veteran support resources provide oncology care teams with guidance, tools, and strategies to deliver coordinated, patient-centered care for veterans across clinical and community settings.

Evaluating the Impact of Oncology Optimized Limited Distribution on Access to Oral Oncology Therapies

April 8, 2026

NCODA partnered with City of Hope and Takeda on a white paper examining how multidisciplinary care teams support patient access, affordability, and continuity of care for oral oncology therapies in metastatic colorectal cancer.

Protecting Patient-Centered Oncology Care from Harmful Step Edits

February 19, 2026

Cancer care depends on delivering the right therapy at the right time. NCODA strongly opposes step therapy policies in oncology, as they delay appropriate treatment, increase the risk of avoidable complications and drug waste, and undermine the cost-avoidance benefits achieved through medically integrated oncology care.

PEComa Care Delivery Across the Academic–Community Oncology Continuum

January 13, 2026

Perivascular epithelioid cell tumors (PEComas) are ultra-rare mesenchymal malignancies that present significant diagnostic and treatment challenges across oncology settings. This white paper examines PEComa care delivery across the academic–community oncology continuum, using real-world perspectives from both settings to illustrate how diagnosis, treatment, and long-term management are operationalized in practice.

NCODA 2025 Fall Summit: Championing a Decade of Impact in Medically Integrated Oncology Care

October 15, 2025

As the 2025 NCODA Fall Summit begins this afternoon in Orlando, we are excited to welcome oncology professionals from across the country for three days of education, collaboration, and innovation—building on ten years of advancing the medically integrated model of care. This year’s Summit theme, “Championing Medically Integrated Oncology: Celebrating a Decade of Impact,” recognizes the progress and the remarkable contributions of our members who continue to elevate oncology care and transform patients’ lives.